EMA — authorised 26 April 2019
- Marketing authorisation holder: Portola Netherlands BV
- Status: approved
🇪🇺 Anxa in European Union
EMA authorised Anxa on 26 April 2019
Marketing authorisation
Anxa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in European Union
Frequently asked questions
Is Anxa approved in European Union?
Yes. EMA authorised it on 26 April 2019.
Who is the marketing authorisation holder for Anxa in European Union?
Portola Netherlands BV holds the EU marketing authorisation.